Fidelity Investments
KYNB

Fidelity Investments’s Kyntra Bio KYNB Stock Holding History

Fidelity Investments’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-417
Closed -$3.23K – 5382
2025
Q1 		$3.23K Sell
417
-16,166
-97% -$194K ﹤0.01% 4805
2024
Q4 		$220K Buy
16,583
+1,253
+8% +$11.6K ﹤0.01% 3232
2024
Q3 		$153K Buy
15,330
+2,742
+22% +$41.4K ﹤0.01% 3294
2024
Q2 		$281K Buy
12,588
+779
+7% +$24.1K ﹤0.01% 2921
2024
Q1 		$694K Sell
11,809
-1,837
-13% -$79.1K ﹤0.01% 2612
2023
Q4 		$302K Buy
13,646
+781
+6% +$11.8K ﹤0.01% 2823
2023
Q3 		$278K Buy
12,865
+5,148
+67% +$202K ﹤0.01% 2781
2023
Q2 		$521K Sell
7,717
-3,390
-31% -$1.4M ﹤0.01% 2647
2023
Q1 		$5.18M Buy
11,107
+10,650
+2,330% +$5.63M ﹤0.01% 2083
2022
Q4 		$183K Sell
457
-2,535
-85% -$971K ﹤0.01% 3031
2022
Q3 		$973K Buy
2,992
+15
+0.5% +$4.83K ﹤0.01% 2614
2022
Q2 		$786K Sell
2,977
-17
-0.6% -$4.34K ﹤0.01% 2735
2022
Q1 		$900K Buy
2,994
+2,856
+2,070% +$996K ﹤0.01% 2809
2021
Q4 		$48K Sell
138
-31,007
-100% -$9.65M ﹤0.01% 3241
2021
Q3 		$7.96M Sell
31,145
-114,155
-79% -$40.4M ﹤0.01% 2204
2021
Q2 		$96.7M Sell
145,300
-83,467
-36% -$48.1M 0.01% 1131
2021
Q1 		$199M Sell
228,767
-7,299
-3% -$7.77M 0.02% 793
2020
Q4 		$219M Sell
236,066
-28,089
-11% -$29.5M 0.02% 711
2020
Q3 		$272M Buy
264,155
+7,386
+3% +$7.95M 0.03% 523
2020
Q2 		$260M Sell
256,769
-135,609
-35% -$126M 0.03% 504
2020
Q1 		$341M Buy
392,378
+15,010
+4% +$14.9M 0.05% 341
2019
Q4 		$405M Buy
377,368
+28,269
+8% +$28.9M 0.04% 391
2019
Q3 		$323M Sell
349,099
-34,015
-9% -$37.4M 0.04% 453
2019
Q2 		$433M Sell
383,114
-18,077
-5% -$19.8M 0.05% 367
2019
Q1 		$545M Buy
401,191
+10,782
+3% +$14.6M 0.07% 296
2018
Q4 		$452M Buy
390,409
+31,160
+9% +$35M 0.06% 307
2018
Q3 		$546M Sell
359,249
-315,485
-47% -$486M 0.06% 301
2018
Q2 		$1.06B Buy
674,734
+401,183
+147% +$523M 0.12% 160
2018
Q1 		$316M Buy
273,551
+2,381
+0.9% +$3.14M 0.04% 496
2017
Q4 		$321M Buy
271,170
+5,508
+2% +$6.91M 0.04% 509
2017
Q3 		$357M Buy
265,662
+132,222
+99% +$139M 0.04% 457
2017
Q2 		$108M Buy
133,440
+65,657
+97% +$45.7M 0.01% 951
2017
Q1 		$41.8M Buy
67,783
+6,446
+11% +$3.93M 0.01% 1394
2016
Q4 		$32.8M Buy
61,337
+25,781
+73% +$12.9M ﹤0.01% 1487
2016
Q3 		$18.4M Buy
35,556
+96
+0.3% +$45.2K ﹤0.01% 1722
2016
Q2 		$14.5M Sell
35,460
-5,536
-14% -$2.53M ﹤0.01% 1807
2016
Q1 		$21.8M Sell
40,996
-784
-2% -$391K ﹤0.01% 1622
2015
Q4 		$31.8M Buy
41,780
+4,360
+12% +$2.89M ﹤0.01% 1453
2015
Q3 		$20.5M Buy
37,420
+15,356
+70% +$9.3M ﹤0.01% 1647
2015
Q2 		$13M Sell
22,064
-9,902
-31% -$5.76M ﹤0.01% 1917
2015
Q1 		$25.1M Sell
31,966
-12,501
-28% -$9.69M ﹤0.01% 1649
2014
Q4 		$30.4M Buy
+44,467
New +$28.6M ﹤0.01% 1561

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments's KYNB Position: Q2 2025 in Review

Fidelity Investments sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 417 shares — an estimated $3.23K sold.

Fidelity Investments first reported a position in KYNB in Q4 2014 and held it in 42 quarters. The position peaked at $1.06B in Q2 2018. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

  • Fidelity Investments reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
  • Fidelity Investments sold 417 Kyntra Bio shares in Q2 2025, an estimated $3.23K.
  • Fidelity Investments first reported a position in Kyntra Bio in Q4 2014 and held it in 42 quarters.
  • Fidelity Investments's Kyntra Bio position peaked at $1.06B in Q2 2018.
  • 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.